At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 16 enrolled
Drug / intervention
POMx +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Pomegranate Polyphenols on Neuropsychological Functioning Following Ischemic Stroke
In Brief
A Phase 2 clinical trial evaluating POMx and Placebo for Stroke. Completed, enrolled 16 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether pomegranate supplements improve cognitive functioning following stroke.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 2015
Enrollment StartJun 2015
Primary CompletionApr 2016
TodayJul 2026
First PostedMay 13, 2015
Enrollment StartJun 1, 2015
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.1 years ago
Interventions
POMxdietary
Pomegranate supplement (1g) by mouth twice per day for 7 days
Placeboother
Placebo (for POMx, containing no antioxidant contents; 1g) capsule by mouth twice per day for 7 days